• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC NEUROSURGERY PERITONEAL CATHETER WITH BIOGLIDE AND 8 SLITS; SHUNT, CENTRAL NERVOUS SYSTEM AND COMPONENTS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC NEUROSURGERY PERITONEAL CATHETER WITH BIOGLIDE AND 8 SLITS; SHUNT, CENTRAL NERVOUS SYSTEM AND COMPONENTS Back to Search Results
Model Number 27536
Device Problem Appropriate Term/Code Not Available (3191)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 07/09/2019
Event Type  Injury  
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
It was reported the ventriculoperitoneal shunt procedure was performed by dorsal horn puncture by the physician, and the flow was checked during the operation.In order to check the valve function during the postoperative process, pumping of the reservoir was performed, and reservoir remained recessed.A revision was performed with suspicion of a ventral obstruction.Aneurysms had been performed multiple times, and the protein concentration seemed to be high.The contrast agent flow from the reservoir but remained stagnant near the neck.However, it was unknown whether the contrast agent flowed little by little, it could be confirmed intermittently on the ventral side by x-ray.
 
Manufacturer Narrative
The returned catheter was attached to the valve for (b)(4) with a suture.A string connected the catheter with another segment of a catheter.The catheter met the requirements for leak and patency testing.Therefore, the nature of the complaint could not be replicated by laboratory personnel.There was damage to one of the ends of the catheter.It is unknown how this damage occurred.The instructions for use cautions, ¿improper handling or use of instruments when implanting shunt components may result in the cutting, slitting, crushing or breaking of components.¿ proteinaceous debris was observed on the catheter.The instructions for use cautions, ¿shunt obstruction may occur in any of the components of the shunt system.The ventricular catheter may become occluded by particulate matter such as blood clots or brain fragments¿¿ all catheters are 100% inspected at the time of manufacture.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PERITONEAL CATHETER WITH BIOGLIDE AND 8 SLITS
Type of Device
SHUNT, CENTRAL NERVOUS SYSTEM AND COMPONENTS
Manufacturer (Section D)
MEDTRONIC NEUROSURGERY
125 cremona drive
goleta CA 93117
Manufacturer (Section G)
MEDTRONIC NEUROSURGERY
125 cremona drive
goleta CA 93117
Manufacturer Contact
katcha taylor
9775 toledo way
irvine,ca, MN 92618
7635263305
MDR Report Key8846410
MDR Text Key152799940
Report Number2021898-2019-00301
Device Sequence Number1
Product Code JXG
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K951258
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 09/10/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/31/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number27536
Device Catalogue Number27536
Device Lot NumberE53963
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer07/26/2019
Is the Reporter a Health Professional? Yes
Date Manufacturer Received08/21/2019
Was Device Evaluated by Manufacturer? Yes
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
-
-